Kopmar, Noam E.
Othus, Megan http://orcid.org/0000-0001-8176-6371
Gardner, Kelda M.
Shaw, Carole
Halpern, Anna B.
Scott, Bart L.
Hendrie, Paul C.
Walter, Roland B. http://orcid.org/0000-0002-9268-3341
Becker, Pamela S. http://orcid.org/0000-0001-6235-9463
Estey, Elihu H.
Percival, Mary-Elizabeth M. http://orcid.org/0000-0002-7016-951X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI 5 P30 CA015704-46)
Article History
Received: 17 September 2021
Revised: 5 December 2021
Accepted: 10 January 2022
First Online: 20 January 2022
Competing interests
: ABH: <i>Research Funding:</i> Pfizer (1/2018–1/2019), Nohla Therapeutics (1/2018–1/2019), Jazz Pharmaceuticals (4/2020—present), Imago Pharmaceuticals, Novartis, Bayer, Tolero Pharmaceuticals consulting<i>:</i> agios pharmaceuticals.